Literature DB >> 23725833

Protective effects of shengmai san and its three fractions on cerebral ischemia-reperfusion injury.

Lai-Hong Li1, Jun-Song Wang, Ling-Yi Kong.   

Abstract

AIM: To investigate the antioxidant and anti-inflammatory effects of Shengmai San (SMS) and its ethyl acetate extract (SEa), n-butanol extract (SBu), and aqueous extract (SWe), and clarify the material base of SMS and the roles played by its fractions.
METHODS: A mouse model of transient forebrain ischemia/reperfusion (I/R) by means of common carotid artery occlusion (CCAO) was used to investigate the effects of SMS and its three fractions. Histopathological damage, blood-brain barrier disruption, and antioxidant and inflammation-related parameters, including malondialdehyde (MDA), superoxide dismutase (SOD), glutathione peroxidase (GPx), myeloperoxidase (MPO), nitric oxide (NO), tumor necrosis factor-α (TNF-α) were measured. The chemical constituents of each fraction were identified by LC-MS.
RESULTS: Eighteen lignans in SEa, and thirteen steroidal glycosides and ginsenosides in SBu were determined. SMS significantly inhibited I/R induced formation of histological injury and cerebral MPO activity. SMS showed the strongest antioxidant and anti-inflammatory effects against the I/R-caused injuries. SEa showed higher antioxidant activity than the other two fractions and SBu has a slightly stronger inhibition on the productions of NO and TNF-α.
CONCLUSION: SMS as a whole had the most effective protection against cerebral I/R-caused injuries compared with its fractions, which inferred that it contains different groups of compounds that contribute together to its protective effect.
Copyright © 2013 China Pharmaceutical University. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23725833     DOI: 10.1016/S1875-5364(13)60020-5

Source DB:  PubMed          Journal:  Chin J Nat Med        ISSN: 1875-5364


  10 in total

1.  Methylophiopogonanone A suppresses ischemia/reperfusion-induced myocardial apoptosis in mice via activating PI3K/Akt/eNOS signaling pathway.

Authors:  Fei He; Bang-Long Xu; Cai Chen; Hong-Jing Jia; Ji-Xiong Wu; Xiao-Chen Wang; Jian-Long Sheng; Li Huang; Jing Cheng
Journal:  Acta Pharmacol Sin       Date:  2016-04-11       Impact factor: 6.150

2.  Methylophiopogonanone A Protects against Cerebral Ischemia/Reperfusion Injury and Attenuates Blood-Brain Barrier Disruption In Vitro.

Authors:  Mingbao Lin; Wei Sun; Wan Gong; Zhiyu Zhou; Yasi Ding; Qi Hou
Journal:  PLoS One       Date:  2015-04-21       Impact factor: 3.240

3.  Pharmacokinetic compatibility of ginsenosides and Schisandra Lignans in Shengmai-san: from the perspective of p-glycoprotein.

Authors:  Yan Liang; Yuanyuan Zhou; Jingwei Zhang; Tai Rao; Lijun Zhou; Rong Xing; Qian Wang; Hanxu Fu; Kun Hao; Lin Xie; Guangji Wang
Journal:  PLoS One       Date:  2014-06-12       Impact factor: 3.240

4.  Intravenous injection of saeng maek san - a safe method of treatment in rats.

Authors:  Min-Ji Choi; Sung-Chul Kim; Seung-Hun Cho
Journal:  J Pharmacopuncture       Date:  2014-06

5.  Pharmacokinetic Comparison of 20(R)- and 20(S)-Ginsenoside Rh1 and 20(R)- and 20(S)-Ginsenoside Rg3 in Rat Plasma following Oral Administration of Radix Ginseng Rubra and Sheng-Mai-San Extracts.

Authors:  Xiaomei Fan; Yan Xu; Danni Zhu; Yibing Ji
Journal:  Evid Based Complement Alternat Med       Date:  2017-05-23       Impact factor: 2.629

6.  A Strategy for Selecting "Q-Markers" of Chinese Medical Preparation via Components Transfer Process Analysis with Application to the Quality Control of Shengmai Injection.

Authors:  Chunxia Zhao; Huan Liu; Peiqi Miao; Houen Wang; Heshui Yu; Chunhua Wang; Zheng Li
Journal:  Molecules       Date:  2019-05-10       Impact factor: 4.411

7.  Efficacy and Safety of Ojeok-San Plus Saengmaek-San for Gastroesophageal Reflux-Induced Chronic Cough: A Pilot, Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Yee Ran Lyu; Kwan-Il Kim; Changsop Yang; So-Young Jung; O Jin Kwon; Hee-Jae Jung; Jun-Hwan Lee; Beom-Joon Lee
Journal:  Front Pharmacol       Date:  2022-03-01       Impact factor: 5.810

8.  Shengmai San Ameliorates Myocardial Dysfunction and Fibrosis in Diabetic db/db Mice.

Authors:  Juan Zhao; Tong-Tong Cao; Jing Tian; Hui-Hua Chen; Chen Zhang; Hong-Chang Wei; Wei Guo; Rong Lu
Journal:  Evid Based Complement Alternat Med       Date:  2016-04-21       Impact factor: 2.629

Review 9.  Ameliorating effects of traditional Chinese medicine preparation, Chinese materia medica and active compounds on ischemia/reperfusion-induced cerebral microcirculatory disturbances and neuron damage.

Authors:  Kai Sun; Jingyu Fan; Jingyan Han
Journal:  Acta Pharm Sin B       Date:  2015-01-24       Impact factor: 11.413

Review 10.  Mitochondrial MPTP: A Novel Target of Ethnomedicine for Stroke Treatment by Apoptosis Inhibition.

Authors:  Yangxin Li; Jiayi Sun; Ruixia Wu; Jinrong Bai; Ya Hou; Yong Zeng; Yi Zhang; Xiaobo Wang; Zhang Wang; Xianli Meng
Journal:  Front Pharmacol       Date:  2020-03-25       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.